RPG Life Sciences Faces New Rs 10.8 Mn Tax Demand In Latest Order

RPG Life Sciences Limited, an integrated pharmaceutical player focusing on formulations, generics, and APIs across domestic and international markets, disclosed receiving a new tax order for Rs 10.8 million. This follows a prior GST related demand of Rs 20.5 million in November 2025, highlighting persistent tax scrutiny on its operations in areas like nephrology, oncology, and cardiology therapeutics. Such orders are routine for pharma firms and often contested, with the company likely to appeal based on past patterns.
​
Order Highlights

• Total tax demand stands at Rs 10.8 million from latest order
• ​Previous GST notice was Rs 20.5 million in November 2025
• ​Covers operations in formulations and APIs segments
• ​Presence in 10 therapeutic areas including oncology and diabetology

​
Sources: MarketScreener, Reuters